Clinical significance of minimal residual disease in B-lineage acute lymphoblastic leukemia pediatric patients with different fusion gene backgrounds

Tong WEI; Xiao-Juan CHEN; Lu-Yang ZHANG; Ao-Li ZHANG; Xiao-Fan ZHU.
Chinese Journal of Contemporary Pediatrics ; (12): 1279-1285, 2020.
Artículo en Zh | WPRIM | ID: wpr-879790

Documentos relacionados

  1. [Clinical significance of minimal residual disease in B-lineage acute lymphoblastic leukemia pediatric patients with different fusion gene backgrounds].
  2. Prognostic significance of IKZF1 deletions and IKZF1<sup>plus</sup> profile in children with B-cell precursor acute lymphoblastic leukemia treated according to the ALL-IC BFM 2009 protocol.
  3. CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
  4. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.
  5. A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.
  6. Refining risk stratification in paediatric B-acute lymphoblastic leukaemia: Combining IKZF1<sup>plus</sup> and Day 15 MRD positivity.
  7. Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.
  8. Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.
  9. Cuplike nuclei in B-cell acute lymphoblastic leukemia with DUX4 rearrangement.
  10. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.